Literature DB >> 2562827

Interleukin-1 beta stimulates somatostatin biosynthesis in primary cultures of fetal rat brain.

D E Scarborough1, S L Lee, C A Dinarello, S Reichlin.   

Abstract

Interleukin-1 (IL-1), a secretory product of activated macrophages and many other cell types, is an important mediator of the acute phase reaction to infection and to endotoxin administration. Previous reports that GH and TSH secretion are decreased following injection of endotoxin or IL-1 led us to test the hypothesis that IL-1 acts by releasing increased amounts of somatostatin (SS), a hypothalamic factor inhibitory of both GH and TSH release. Primary cultures of dispersed fetal rat diencephalic cells were found to contain increasing amounts of immunoreactive SS in both cells and media after addition of recombinant human IL-1 beta. This increase was detectable at 24 hours and continued for up to 6 days, the longest time interval tested. Increased content of SS peptide was accompanied by marked increases in SS mRNA. These changes were dose-related, the lowest effective dose being 10(-10) M. In contrast to the long term response, exposure of the cells to IL-1 beta for one hour had only minimal stimulating effects on somatostatin release. These data indicate that IL-1 beta is neurotrophic for the somatostatinergic neuron, an action that may be responsible at least in part, for the neuroendocrine response to infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562827     DOI: 10.1210/endo-124-1-549

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Adipocyte, adipose tissue, and infectious disease.

Authors:  Mahalia S Desruisseaux; Maria E Trujillo; Herbert B Tanowitz; Philipp E Scherer
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 2.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

3.  Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.

Authors:  C D Rice; R E Merchant
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

4.  Peripheral endotoxin induces hypothalamic immunoreactive interleukin-1 beta in the rat.

Authors:  E W Hillhouse; K Mosley
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

Review 5.  Cytokines and reproduction.

Authors:  C Simón; M L Polan
Journal:  West J Med       Date:  1994-05

Review 6.  Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinfundibular system.

Authors:  R Toni; R M Lechan
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

7.  Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway.

Authors:  J L Liu; D N Papachristou; Y C Patel
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

8.  Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.

Authors:  A Vezzani; M Conti; A De Luigi; T Ravizza; D Moneta; F Marchesi; M G De Simoni
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

9.  Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice.

Authors:  A Vezzani; D Moneta; M Conti; C Richichi; T Ravizza; A De Luigi; M G De Simoni; G Sperk; S Andell-Jonsson; J Lundkvist; K Iverfeldt; T Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

10.  Expression of somatostatin and its receptor 1-5 in endometriotic tissues and cells.

Authors:  Yanhua Zhao; Lin Peng; Xiang Li; Yi Zhang
Journal:  Exp Ther Med       Date:  2018-09-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.